查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1605912

非侵入性產前檢查市場，規模，佔有率，趨勢，產業分析報告:各妊娠期間，各零件，各方法，各用途，各最終用途，各地區 - 市場預測 2025年～2034年

Non-Invasive Prenatal Testing Market Size, Share, Trends, Industry Analysis Report: By Gestation Period, Component, Method, Application, End Use, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，到 2034 年，非侵入性產前檢測 (NIPT) 市場規模預計將達到 113.9 億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

非侵入性產前檢測 (NIPT) 是指使用孕婦的血液樣本篩檢胎兒某些遺傳性疾病（例如唐氏症）的方法。此測試分析母親血液中循環的胎兒 DNA 小片段。它受到用戶的青睞，因為與侵入性方法相比，它準確且安全。

遺傳疾病早期檢測的重要性日益增加，這是 NIPT 市場的主要推動因素。基因組技術和生物資訊學的重大進步正在推動 NIPT 市場的發展。新一代定序 (NGS) 技術的改進提高了胎兒 DNA 分析的準確性和效率。這些創新帶來了更實惠、更容易獲得的 NIPT 選擇，從而提高了醫療保健提供者和患者對 NIPT 的採用率。例如，2021 年 5 月，Illumina, Inc. 和 Next Generation Genomic Co., Ltd. 宣布推出 VeriSeq NIPT Solution v2，這是一種基於 CE-IVD、NGS 的 NIPT 方法。隨著技術的不斷發展，我們期望看到 NIPT 的功能和定價進一步改進。

非侵入性產前檢測市場是由價格競爭和透過策略合作夥伴關係進行技術創新等策略的激烈競爭所推動的。例如，2021年7月，加州Pacific Biosciences, Inc.宣布收購Omniome。此次收購使 Pacific Biosciences 能夠以有利於客戶的創意方式擴大其定序儀市場機會。 Omniome 憑藉其創新方法，旨在提供高度準確的短鏈定序平台，以進入快速擴展的臨床應用領域，例如非侵入性產前檢測和腫瘤學。

此外，2024 年 10 月，Yourgene Health 在 Genetix 上安裝了哥倫比亞首個非侵入性產前檢測 (NIPT) 工作流程。該服務為哥倫比亞的孕婦提供快速、準確的 NIPT 結果，減少週轉時間和運輸問題。

非侵入性產前檢測 (NIPT) 市場報告亮點

透過方法分析，母體血漿遊離 DNA 檢測在 2024 年佔據市場主導地位，這主要是因為與傳統的侵入性方法相比，其風險最小且準確性更高。

從應用來看，由於NIPT 在檢測21 三體（唐氏症）、18 三體症（愛德華茲症候群）和13 三體（帕陶症候群）等常見染色體異常方面的作用，三體細分市場將在2024 年成為市場。

由於先進的醫療基礎設施、較高的認知度以及先進技術的穩定實施，北美在 2024 年佔據了市場主導地位。

由於經濟成長、技術創新、地理擴張和戰略合作夥伴關係，亞太地區預計將實現最快的複合年增長率。

主要市場參與者包括Agilent Technologies, Inc.，Centogene N.V.，Eurofins LifeCodexx GmbH，F． Hoffmann-La Roche Ltd.(Ariosa Diagnostics)，Agilent Technologies, Inc.(Ariosa Diagnostics)，Illumina, Inc.，Laboratory Corp. of America Holdings，MedGenome Labs Ltd.，Myriad Women's Health, Inc.，Natera, Inc.，Progenity, Inc.，Qiagen，Quest Diagnostics, Inc.，Thermo Fisher Scientific, Inc.

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球非侵入性產前檢查(NIPT)市場洞察

  • 用途概述
  • 非侵入性產前檢查(NIPT)市場動態
    • 促進因素和機會
      • 定序技術和生物資訊學的技術不斷進步
      • 生育年齡增加
    • 抑制因素和挑戰
      • 有些國家禁止將 NIPT 用於基於非醫學背景的性別選擇。
  • PESTEL分析
  • 非侵入性產前檢查(NIPT)市場用途趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球非侵入性產前檢查(NIPT)市場:各妊娠期間

  • 主要調查結果
  • 簡介
  • 0～12週
  • 13～24週
  • 25～36週

第6章 全球非侵入性產前檢查(NIPT)市場:各零件

  • 主要調查結果
  • 簡介
  • 消耗品
  • 設備
  • 軟體
  • 服務

第7章 全球非侵入性產前檢查(NIPT)市場:各方法

  • 主要調查結果
  • 簡介
  • 母體血漿檢驗的脫離DNA
  • 超音波檢測
  • 生物化學篩檢檢驗
  • 其他

第8章 全球非侵入性產前檢查(NIPT)市場:各用途

  • 主要調查結果
  • 簡介
  • 單體性
  • 三體性
  • 微缺失症候群
  • 其他

第9章 全球非侵入性產前檢查(NIPT)市場:各最終用途

  • 主要調查結果
  • 簡介
  • 診斷中心
  • 醫院和診療所

第10章 全球非侵入性產前檢查(NIPT)市場:各地區

  • 主要調查結果
  • 簡介
    • 非侵入性產前檢查(NIPT)市場評估:地區，2020年～2034年
  • 北美
    • 北美:各妊娠期間，2020～2034年
    • 北美:各零件，2020～2034年
    • 北美:各方法，2020～2034年
    • 北美:各用途，2020～2034年
    • 北美:各最終用途，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各妊娠期間，2020～2034年
    • 歐洲:各零件，2020～2034年
    • 歐洲:各方法，2020～2034年
    • 歐洲:各用途，2020～2034年
    • 歐洲:各最終用途，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各妊娠期間，2020～2034年
    • 亞太地區:各零件，2020～2034年
    • 亞太地區:各方法，2020～2034年
    • 亞太地區:各用途，2020～2034年
    • 亞太地區:各最終用途，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各妊娠期間，2020～2034年
    • 中東·非洲:各零件，2020～2034年
    • 中東·非洲:各方法，2020～2034年
    • 中東·非洲:各用途，2020～2034年
    • 中東·非洲:各最終用途，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各妊娠期間，2020～2034年
    • 南美:各零件，2020～2034年
    • 南美:各方法，2020～2034年
    • 南美:各用途，2020～2034年
    • 南美:各最終用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第11章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第12章 企業簡介

  • Agilent Technologies, Inc.
  • Centogene N.V
  • Eurofins LifeCodexx GmbH
  • F;Hoffmann-La Roche Ltd
  • Illumina, Inc
  • Laboratory Corp. of America Holdings
  • MedGenome Labs Ltd
  • Myriad Women's Health, Inc.
  • Natera, Inc.
  • Progenity, Inc.
  • Qiagen
  • Quest Diagnostics, Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: PM1836

The non-invasive prenatal testing market size is expected to reach USD 11.39 billion by 2034, according to a new study by Polaris Market Research. The report "Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Trends, Industry Analysis Report: By Gestation Period (0-12 Weeks, 13-24 Weeks, and 25-36 Weeks), Component, Method, Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Non-invasive prenatal testing (NIPT) refers to a method used to screen for certain genetic conditions in a fetus, such as Down syndrome, using a blood sample from the pregnant individual. This test analyzes small fragments of fetal DNA that are circulating in the maternal blood. It is a preferred option among users for its accuracy and safety compared to invasive methods.

The growing importance of early detection of genetic disorders is a primary driver for the NIPT market. Significant advancements in genomic technology and bioinformatics have propelled the NIPT market. Improvements in next-generation sequencing (NGS) technology have enhanced the accuracy and efficiency of fetal DNA analysis. These technological innovations have led to more affordable and accessible NIPT options, thereby expanding its adoption among healthcare providers and patients. For instance, in May 2021, Illumina, Inc. and Next Generation Genomic Co., Ltd. announced the launch of VeriSeq NIPT Solution v2, a CE-IVD, NGS-based approach to NIPT. As technology continues to evolve, it is expected to improve the capabilities and affordability of NIPT further.

The non-invasive prenatal testing market is driven by intense competition with strategies including price competitiveness and technological innovation with strategic partnerships. For instance, in July 2021, Pacific Biosciences of California, Inc. announced the acquisition of Omniome. With the acquisition, Pacific Biosciences will be able to expand the market opportunity for sequencing in creative ways that benefit customers. Through its innovative methodology, Omniome aims to provide an accurate short-read sequencing platform to enable it to enter rapidly expanding clinical application areas such as non-invasive prenatal testing and oncology.

Additionaly, in October 2024, Yourgene Health installed the first non-invasive prenatal testing (NIPT) workflow in Colombia at Genetix. The service will deliver fast, precise NIPT results for expectant parents in Colombia, serving to reduce turnaround times and delivery problems.

Non-Invasive Prenatal Testing (NIPT) Market Report Highlights

By method analysis, the cell-free DNA in maternal plasma tests segment dominated the market in 2024, mainly attributed to its minimal risk and superior accuracy compared to traditional invasive methods.

By application analysis, the trisomy segment dominated the market in 2024 owing to NIPT's role in detecting common chromosomal abnormalities such as Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome).

North America dominated the market in 2024 due to advanced healthcare infrastructure, high awareness levels, and robust adoption of advanced technologies.

Asia Pacific is expected to register the fastest CAGR, owing to economic growth, technological innovation, geographic expansion, and strategic partnerships.

The key market players include Agilent Technologies, Inc.; Centogene N.V.; Eurofins LifeCodexx GmbH; F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics); Illumina, Inc.; Laboratory Corp. of America Holdings; MedGenome Labs Ltd.; Myriad Women's Health, Inc.; Natera, Inc.; Progenity, Inc.; Qiagen; Quest Diagnostics, Inc.; and Thermo Fisher Scientific, Inc.

Polaris Market Research has segmented the non-invasive prenatal testing market report based on gestation period, component, method, application, end use, and region:

By Gestation Period Outlook (Revenue - USD Billion, 2020-2034)

  • 0-12 weeks
  • 13-24 weeks
  • 25-36 weeks

By Component Outlook (Revenue - USD Billion, 2020-2034)

  • Consumables
  • Instruments
  • Software
  • Services

By Method Outlook (Revenue - USD Billion, 2020-2034)

  • Cell-Free DNA in Maternal Plasma Tests
  • Ultrasound Detection
  • Biochemical Screening Tests
  • Others

By Application Outlook (Revenue - USD Billion, 2020-2034)

  • Monosomy
  • Trisomy
  • Microdeletion Syndrome
  • Others

By End-Use Outlook (Revenue - USD Billion, 2020-2034)

  • Diagnostic Centers
  • Hospitals and Clinics
  • Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Vietnam
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of the Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Non-Invasive Prenatal Testing (NIPT) Market Insights

  • 4.1. Non-Invasive Prenatal Testing (NIPT) Market - Application Snapshot
  • 4.2. Non-Invasive Prenatal Testing (NIPT) Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising technological advancements in sequencing technologies and bioinformatics
      • 4.2.1.2. Rise in Maternal Age
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Application of NIPT for sex selection on non-medical backgrounds is prohibited in some countries.
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Non-Invasive Prenatal Testing (NIPT) Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • 5.3. 0-12 weeks
    • 5.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 0-12 weeks, by Region, 2020-2034 (USD Billion)
  • 5.4. 13-24 weeks
    • 5.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 13-24 weeks, by Region, 2020-2034 (USD Billion)
  • 5.5. 25-36 weeks
    • 5.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 25-36 weeks, by Region, 2020-2034 (USD Billion)

6. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • 6.3. Consumables
    • 6.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Consumables, by Region, 2020-2034 (USD Billion)
  • 6.4. Instruments
    • 6.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Instruments, by Region, 2020-2034 (USD Billion)
  • 6.5. Software
    • 6.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Software, by Region, 2020-2034 (USD Billion)
  • 6.6. Services
    • 6.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Services, by Region, 2020-2034 (USD Billion)

7. Global Non-Invasive Prenatal Testing (NIPT) Market, by Method

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • 7.3. Cell-Free DNA in Maternal Plasma Tests
    • 7.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Cell-Free DNA in Maternal Plasma Tests, by Region, 2020-2034 (USD Billion)
  • 7.4. Ultrasound Detection
    • 7.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Ultrasound Detection, by Region, 2020-2034 (USD Billion)
  • 7.5. Biochemical Screening Tests
    • 7.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Biochemical Screening Tests, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • 8.3. Monosomy
    • 8.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Monosomy, by Region, 2020-2034 (USD Billion)
  • 8.4. Trisomy
    • 8.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Trisomy, by Region, 2020-2034 (USD Billion)
  • 8.5. Microdeletion Syndrome
    • 8.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Microdeletion Syndrome, by Region, 2020-2034 (USD Billion)
  • 8.6. Other
    • 8.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Other, by Region, 2020-2034 (USD Billion)

9. Global Non-Invasive Prenatal Testing (NIPT) Market, by End Use

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • 9.3. Diagnostic Centers
    • 9.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
  • 9.4. Hospitals and Clinics
    • 9.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Billion)

10. Global Non-Invasive Prenatal Testing (NIPT) Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Non-Invasive Prenatal Testing (NIPT) Market - North America
    • 10.3.1. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
    • 10.3.2. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
    • 10.3.3. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
    • 10.3.4. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
    • 10.3.5. North America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.3.7. Non-Invasive Prenatal Testing (NIPT) Market - U.S.
      • 10.3.7.1. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.3.7.2. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.3.7.3. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.3.7.4. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.3.7.5. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.3.8. Non-Invasive Prenatal Testing (NIPT) Market - Canada
      • 10.3.8.1. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.3.8.2. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.3.8.3. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.3.8.4. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.3.8.5. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • 10.4. Non-Invasive Prenatal Testing (NIPT) Market - Europe
    • 10.4.1. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.6. Non-Invasive Prenatal Testing (NIPT) Market - UK
      • 10.4.6.1. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.7. Non-Invasive Prenatal Testing (NIPT) Market - France
      • 10.4.7.1. France: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.8. Non-Invasive Prenatal Testing (NIPT) Market - Germany
      • 10.4.8.1. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.9. Non-Invasive Prenatal Testing (NIPT) Market - Italy
      • 10.4.9.1. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.10. Non-Invasive Prenatal Testing (NIPT) Market - Spain
      • 10.4.10.1. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.11. Non-Invasive Prenatal Testing (NIPT) Market - Netherlands
      • 10.4.11.1. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.12. Non-Invasive Prenatal Testing (NIPT) Market - Russia
      • 10.4.12.1. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.13. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • 10.5. Non-Invasive Prenatal Testing (NIPT) Market - Asia Pacific
    • 10.5.1. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.6. Non-Invasive Prenatal Testing (NIPT) Market - China
      • 10.5.6.1. China: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.7. Non-Invasive Prenatal Testing (NIPT) Market - India
      • 10.5.7.1. India: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.8. Non-Invasive Prenatal Testing (NIPT) Market - Malaysia
      • 10.5.8.1. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.9. Non-Invasive Prenatal Testing (NIPT) Market - Japan
      • 10.5.9.1. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.10. Non-Invasive Prenatal Testing (NIPT) Market - Indonesia
      • 10.5.10.1. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.11. Non-Invasive Prenatal Testing (NIPT) Market - South Korea
      • 10.5.11.1. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.12. Non-Invasive Prenatal Testing (NIPT) Market - Australia
      • 10.5.12.1. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.13. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • 10.6. Non-Invasive Prenatal Testing (NIPT) Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.6. Non-Invasive Prenatal Testing (NIPT) Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.7. Non-Invasive Prenatal Testing (NIPT) Market - UAE
      • 10.6.7.1. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.8. Non-Invasive Prenatal Testing (NIPT) Market - Israel
      • 10.6.8.1. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.9. Non-Invasive Prenatal Testing (NIPT) Market - South Africa
      • 10.6.9.1. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.10. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • 10.7. Non-Invasive Prenatal Testing (NIPT) Market - Latin America
    • 10.7.1. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.7.6. Non-Invasive Prenatal Testing (NIPT) Market - Mexico
      • 10.7.6.1. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.7.7. Non-Invasive Prenatal Testing (NIPT) Market - Brazil
      • 10.7.7.1. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.7.8. Non-Invasive Prenatal Testing (NIPT) Market - Argentina
      • 10.7.8.1. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.7.9. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Agilent Technologies, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Centogene N.V
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Eurofins LifeCodexx GmbH
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. F; Hoffmann-La Roche Ltd
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Illumina, Inc
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Laboratory Corp. of America Holdings
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. MedGenome Labs Ltd
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Myriad Women's Health, Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Natera, Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Progenity, Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Qiagen
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Quest Diagnostics, Inc.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development
  • 12.13. Thermo Fisher Scientific, Inc.
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Benchmarking
    • 12.13.4. Recent Development

List of Tables:

  • Table 1 Global Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 2 Global Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 3 Global Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 4 Global Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 5 Global Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 6 North America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 7 North America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 8 North America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 9 North America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 10 North America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 11 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 12 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 13 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 14 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 15 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 17 Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 18 Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 19 Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 20 Canada: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 22 Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 23 Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 24 Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 25 Europe: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 26 UK: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 27 UK: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 28 UK: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 29 UK: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 30 UK: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 France: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 32 France: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 33 France: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 34 France: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 35 France: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 36 Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 37 Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 38 Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 39 Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 40 Germany: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 42 Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 43 Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 44 Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 45 Italy: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 47 Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 48 Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 49 Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 50 Spain: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 56 Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 57 Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 58 Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 59 Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 60 Russia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 71 China: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 72 China: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 73 China: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 74 China: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 75 China: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 India: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 77 India: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 78 India: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 79 India: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 80 India: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 86 Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 87 Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 88 Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 89 Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Japan: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 96 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 97 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 98 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 99 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 100 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 101 Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 102 Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 103 Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 104 Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 105 Australia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 121 UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 122 UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 123 UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 124 UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 125 UAE: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 126 Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 127 Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 128 Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 129 Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 130 Israel: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 131 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 132 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 133 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 134 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 135 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 141 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 142 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 143 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 144 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 145 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 146 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 147 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 148 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 149 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 150 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 151 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 152 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 153 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 154 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 155 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 156 Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 157 Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 158 Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 159 Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 160 Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • List of Figures:
  • Figure 1. Global Non-Invasive Prenatal Testing (NIPT) Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Gestation Period
  • Figure 7. Global Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Component
  • Figure 9. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Method
  • Figure 11. Global Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Application
  • Figure 13. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 14. Market by End Use
  • Figure 15. Global Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2024 & 2034 (USD Billion)